We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Relieving Endoplasmic Reticulum Stress May Prevent Some Types of Chronic Disease

By LabMedica International staff writers
Posted on 08 Jul 2015
A team of cell biologists has identified an enzyme that protects cells against endoplasmic reticulum (ER) stress and prevents the apoptosis that characterizes such chronic diseases as Wolfram syndrome, diabetes, heart disease, and Parkinson's disease.

Among its many activities, the endoplasmic reticulum folds and modifies newly formed proteins so they have the correct three-dimensional shape to function properly. More...
The ER also helps transport proteins, fats, and other materials to specific sites within the cell or to the cell surface. When placed under certain types of stress, the ER can leak molecules into other parts of the cell, which can trigger the apoptotic pathway that leads to cell death and eventually to organ dysfunction.

Investigators at Washington University School of Medicine (St. Louis, MO, USA) reported in the June 23, 2015, on line edition of the journal Science Signaling that they had identified a mechanism by which the enzyme IRE1 conferred protection against ER stress-mediated cell death. In humans, IRE1 is called "ER to nucleus signaling 1 protein." This protein possesses intrinsic kinase activity and an endoribonuclease activity, and it is important in altering gene expression as a response to ER-based stress signals.

The investigators found that IRE1 signaling prevented ER membrane permeabilization mediated by the proteins Bax and Bak and cell death in cells experiencing ER stress. In response to ER stress, cells deficient in IRE1 were found to be susceptible to leakage of ER contents, which was associated with the accumulation of calcium in mitochondria, oxidative stress in the cytosol, and ultimately cell death.

Senior author Dr. Fumihiko Urano, professor of medicine at Washington University School of Medicine, said, "We believe the enzyme we identified may provide us with a target to protect many types of cells from a death cascade that leads to those different, seemingly unrelated disorders. It is clear from our experiments that this enzyme can keep the membrane in the cell from becoming permeable and leaking. We think it may be possible to prevent Wolfram syndrome and other diseases related to this type of cellular stress by targeting the enzyme to make the membrane stronger."

Related Links:

Washington University School of Medicine



New
Gold Member
Automatic Hematology Analyzer
CF9600
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Electrolyte Analyzer
BKE-B
New
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.